Robert M. Mader

171 papers receiving 3.8k citations

Robert M. Mader's Hit Papers

Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial 2023 · 94 citations
940+1+2Years since publication255075

Peers

Robert M. Mader
Comparison fields: 5 of 150
  • Chemical Health and Safety 49
  • Occupational Therapy 219
  • Oncology 1.4k
  • Cancer Research 743
  • Pollution 324
Replace Richard J. Albertini with:
Richard J. Albertini United States
G. Wynne Aherne United Kingdom
D. Schmähl Germany
E. A. de Bruijn Belgium
D Belpomme France
Chun‐Ming Wong Hong Kong
Marc Benderitter France
Patrick J. Creaven United States
Hossein Mozdarani Iran
Sarah A. Taylor United States
Robert M. Mader relative to Richard J. Albertini United States Richard J. Albertini's profile →
Citations per field
00.5×4.1×
Richard J. Albertini · 1×
Citations per year

Countries citing papers authored by Robert M. Mader

Since Specialization
Citations

This map shows the geographic impact of Robert M. Mader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert M. Mader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert M. Mader more than expected).

Fields of papers citing papers by Robert M. Mader

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert M. Mader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert M. Mader. The network helps show where Robert M. Mader may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert M. Mader, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert M. Mader Line = papers co-authored together Robert M. Mader links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 176 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2006193
2 2005125
3 2007113
4 2007106
5 200797
6
Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial
Hit paper breakdown →
202394
7 200493
8 200588
9 199887
10 200385
11 200783
12
5-fluorouracil kinetics in the interstitial tumor space: clinical response in breast cancer patients.
199775
13 199473
14 201672
15 201569
16 200369
17 201268
18 201160
19 200957
20 201153

About Robert M. Mader

Robert M. Mader is a scholar working on Oncology, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 176 papers that have together received 3.9k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (38 papers), Colorectal Cancer Treatments and Studies (28 papers), HER2/EGFR in Cancer Research (22 papers), Chemotherapy-related skin toxicity (15 papers), Cancer Genomics and Diagnostics (13 papers), Safe Handling of Antineoplastic Drugs (11 papers), Lung Cancer Treatments and Mutations (11 papers) and Genetic factors in colorectal cancer (10 papers). The work is most often cited by research in Chemical Health and Safety (49 citations), Occupational Therapy (219 citations), Oncology (1.4k citations), Cancer Research (743 citations) and Pollution (324 citations). Robert M. Mader has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Guenther G. Steger, Blanka Rizovski, Maria Fuerhacker, Günther Steger, Rupert Bartsch, Ursula Pluschnig, Christoph Zielinski, Michael Gnant, Susanne N. Mahnik and Margaretha Rudas. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, British Journal of Cancer, Breast Cancer Research and Treatment and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact